Allergic rhinitis
Conditions
Interventions
A: Group A: First procedure: Left-sided ultrasound-guided sphenopalatine nerve block (3ml 1% lidocaine injection + 2mg dexamethasone sodium phosphate injection)
Second procedure: Right-sided ultrasound-guided sphenopalatine nerve block (3ml 1% lidocaine injection + 2mg dexamethasone sodium phosphate injection)
Third procedure: Left-sided ultrasound-guided sphenopalatine nerve block (3ml 1% lidocaine injection + 2mg dexamethasone sodium phosphate injection)
Fourth procedure: Right-sided ultrasound-guided sphenopalatine nerve block (3ml 1% lidocaine injection + 2mg dexamethasone sodium phosphate injection). Additional consolidation therapy may be administ
B:Group B: First procedure: Left hypopharyngeal nerve block under ultrasound guidance (1% lidocaine injection 3ml + dexamethasone sodium phosphate injection 2mg + vitamin B120.25mg). Second procedure:
C:Group C: The procedure was performed in three stages. During the first session, left-sided ultrasound-guided sphenopalatine nerve block (3ml lidocaine + 2mg dexamethasone phosphate injection) combin
Sponsors
No.10, West First Road, South Second Road, Shihezi City
Eligibility
Sex/Gender
All
Age
12 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1 The study included patients of all genders aged 12-70 years with ASAI-II classification. All participants met the diagnostic criteria for allergic rhinitis outlined in the 2015 edition of the "Diagnostic and Treatment Guidelines for Allergic Rhinitis", exhibiting characteristic symptoms such as sneezing, nasal itching, watery nasal discharge, and nasal congestion. Patients were confirmed to be sensitized through skin prick tests or serum-specific IgE testing. 2 All participants voluntarily enrolled in the study after signing informed consent documents 3 All patients being at least 12 years old.
Exclusion criteria
Exclusion criteria: 1 Patients with organic lesions in the nasal cavity, nasopharynx, etc., requiring otolaryngological consultation; 2 Active sinusitis, nasal polyps, suspected nasopharyngeal tumors, or patients with prior nasal surgery requiring initial condition assessment; 3 Severe infections with puncture site contamination; 4 Allergy to medications, severe coagulation disorders, or use of potent anticoagulants/platelet inhibitors; 5 Patients with anatomical abnormalities, uncontrolled glaucoma pressure, or other contraindications; 6 Patients with cardiac, hepatic, or renal diseases; 7 Female patients during pregnancy or lactation; 8 Patients with orbital or intracranial complications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rhinoconjunctivitis Quality of Life Questionnaire;Total Nasal Symptom Score (TNSS); | — |
Countries
China
Contacts
Public ContactWu xiulin
Department of Anesthesia and Perioperative Medicine, Shihezi People's Hospital, Xinjiang
Outcome results
None listed